Bhupinder Mann, MBBS,
Head - Genitourinary and Brain Cancer Therapeutics

Dr. Bhupinder Mann joined the Clinical Investigations Branch at CTEP in September 2008. He has the Genitourinary and Brain Cancers therapeutic clinical trials portfolio at CIB/CTEP and is the assigned CIB scientific liaison to the Southwest Oncology Group (SWOG).

Dr. Mann came to the CTEP from the Food and Drug Administration (FDA) where he was a Medical Officer and Acting Team Leader in the Office of Oncology Drug Products (OODP) at the Center for Drug Evaluation and Research (CDER) from 2004 to 2008.

Dr. Mann received his MBBS degree in 1983 from the Government Medical College and Rajendra Hospital at Patiala, in the state of Punjab, India. He was a resident and chief-resident in Internal Medicine in the Department of Medicine at Harper Hospital and Detroit Medical Center at the Wayne State University School of Medicine in Detroit, Michigan from 1987-91. He completed a fellowship in Hematology & Medical Oncology from 1991-94 at the Mayo Clinic in Rochester, Minnesota, and was a clinical fellow on the Bone Marrow Transplantation Service at the Mayo Clinic in 1995. He is Board-Certified in Internal Medicine (1991), Hematology (1994), and Medical Oncology (1995, 2007).

Dr. Mann served as an attending physician and Division Chief in the Division of Hematology and Medical Oncology in the Department of Medicine at Alameda County Medical Center/Highland General Hospital in Oakland, California from 1996 to 1999. He was a Consultant in Medical Oncology at the King Faisal Specialist Hospital and Research Center in Riyadh, Saudi Arabia and later a Senior Consultant in Medical Oncology at the National Cancer Center in Singapore before joining the FDA in 2004.

Contact Information:
National Cancer Institute
6130 Executive Blvd., Suite 7034
Bethesda, MD 20892-7436
Phone: 301-496-2522
E-mail: mannb@mail.nih.gov